EDITORIAL
Published on 21 Oct 2021
Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
doi 10.3389/fimmu.2021.781872
- 1,876 views
- 3 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
61k
Total Downloads
187k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 31 Mar 2021
High Throughput Multi-Omics Approaches for Clinical Trial Evaluation and Drug Discovery
doi 10.3389/fimmu.2021.590742
- 11,796 views
- 44 citations
ORIGINAL RESEARCH
Published on 25 Mar 2021
Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types
doi 10.3389/fonc.2021.558248
- 5,570 views
- 23 citations
SYSTEMATIC REVIEW
Published on 19 Mar 2021
Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis
doi 10.3389/fonc.2021.538174
- 3,097 views
- 16 citations
ORIGINAL RESEARCH
Published on 24 Feb 2021
Triple-Negative Breast Cancer: Intact Mismatch Repair and Partial Co-Expression of PD-L1 and LAG-3
doi 10.3389/fimmu.2021.561793
- 4,167 views
- 26 citations
MINI REVIEW
Published on 11 Feb 2021
Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events—A Comprehensive Review
doi 10.3389/fonc.2020.585311
- 11,514 views
- 99 citations
ORIGINAL RESEARCH
Published on 15 Jan 2021
Incidence of Skin and Respiratory Immune-Related Adverse Events Correlates With Specific Tumor Types in Patients Treated With Checkpoint Inhibitors
doi 10.3389/fonc.2020.570752
- 2,700 views
- 24 citations
ORIGINAL RESEARCH
Published on 12 Nov 2020
Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy
doi 10.3389/fimmu.2020.584423
- 10,319 views
- 49 citations
CLINICAL TRIAL
Published on 09 Nov 2020
Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial
doi 10.3389/fimmu.2020.595035
- 4,143 views
- 20 citations
SYSTEMATIC REVIEW
Published on 21 Oct 2020
Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review
doi 10.3389/fimmu.2020.01354
- 8,033 views
- 28 citations
ORIGINAL RESEARCH
Published on 19 Oct 2020
A Novel Signature of 23 Immunity-Related Gene Pairs Is Prognostic of Cutaneous Melanoma
doi 10.3389/fimmu.2020.576914
- 3,080 views
- 14 citations
REVIEW
Published on 14 Oct 2020
Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses
doi 10.3389/fimmu.2020.587014
- 14,346 views
- 73 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 187kTopic views
- 123kArticle views
- 61kArticle downloads